GMS Ventures & Investments - 11 Mar 2025 SCHEDULE 13D/A Report for Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share (OTLK)

Filing Manager: GMS Ventures & Investments
Reporting Manager: SUKHTIAN GHIATH M.
Security: Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: OTLK
Shares outstanding: 38,903,334 shares
Disclosed Ownership: 16,183,787 shares
Ownership: 42%
Form type: SCHEDULE 13D/A
Filing time: 12 Mar 2025, 21:11:16 UTC
Date of event: 11 Mar 2025
Previous filing: 22 Jan 2025
Next filing: 28 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GMS VENTURES & INVESTMENTS	42%	16,183,187	0	16,183,787	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001804598
SUKHTIAN GHIATH M.	42%	16,183,787	0	16,183,787	/s/ Lawrence A. Kenyon	Lawrence A. Kenyon/Attorney-in-Fact	0001717441